Bio Pharma Dive
MARCH 24, 2023
Series A rounds have been easy to secure in the last few years, but industry watchers say they haven't seen a corresponding increase in Series B's as startups struggle to recruit new investors
Pharmaceutical Technology
MARCH 22, 2023
In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. It was a money-saving strategy that was paying off until Covid-19 hit.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MARCH 22, 2023
Armed with a $50 million Series A round, the startup is building off of research from a lab run by protein engineering pioneer Jim Wells
FDA Law Blog
MARCH 19, 2023
Hyman, Phelps & McNamara, P.C.’s s Mark Tobolowsky co-authored the peer-reviewed article “ Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials ” in the recently published edition of Human Gene Therapy.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
Fierce Pharma
MARCH 22, 2023
AbbVie's blockbuster-to-be Parkinson's combo hits a wall as FDA questions delivery pump aliu Wed, 03/22/2023 - 11:17
Pharma Times
MARCH 23, 2023
Eladocagene exuparvovec is for children with ultra-rare genetic disorder in final draft guidance
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
MARCH 20, 2023
The Rise, Fall and Future of Novavax 3/21/2023
Fierce Pharma
MARCH 22, 2023
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD kdunleavy Thu, 03/23/2023 - 01:37
Pharma Times
MARCH 22, 2023
Measures include a requirement to publicly register studies and share results among research participants
Bio Pharma Dive
MARCH 23, 2023
The two companies gained billions of dollars in market value after their antibody drug succeeded against a disease that’s been difficult to treat with biologic medicines
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Pharmaceutical Technology
MARCH 20, 2023
BioNTech has signed an exclusive worldwide licence and collaboration agreement with OncoC4 to co-develop and commercialise a new checkpoint antibody in multiple solid tumour indications.
BioPharma Reporter
MARCH 20, 2023
Samsung Biologics will begin construction of Plant 5 within the first half of this year: marking the first facility for its second Bio Campus. Upstream Processing
Fierce Pharma
MARCH 22, 2023
After appeals loss, Johnson & Johnson will take Texas two-step case to the US Supreme Court kdunleavy Wed, 03/22/2023 - 14:39
Pharma Times
MARCH 20, 2023
Company will also operate work on particular initiatives across an additional five neonatal sites
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Bio Pharma Dive
MARCH 22, 2023
The companies will collaborate to identify compounds that could treat insulin resistance by targeting shape-shifting cellular droplets known as biomolecular condensates
Pharmaceutical Technology
MARCH 20, 2023
RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines.
BioSpace
MARCH 21, 2023
Gilead’s Yescarta Bests Long-Time Standard of Care in R/R LBCL Overall Survival 3/22/2023
Fierce Pharma
MARCH 23, 2023
AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda aliu Thu, 03/23/2023 - 10:23
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Pharma Times
MARCH 22, 2023
Study involves SFX-01 candidate and emerging preliminary pharmacokinetic data from study
Bio Pharma Dive
MARCH 22, 2023
Stéphane Bancel said his company's planned price hike covers the higher costs of commercial sales. Bernie Sanders called it part of industry’s “unprecedented level of corporate greed &rdquo
Pharmaceutical Technology
MARCH 20, 2023
Pharma companies and world health stand to benefit from new technologies, but it’s a tough time to be an investor – and an even tougher one for firms seeking investment. From close to zero, central bank interest rates have risen to 3% in the Eurozone, 4% in the UK and nearly 5% in the USA.
BioSpace
MARCH 22, 2023
FDA Adcomm Backs Accelerated Approval of Biogen’s Tofersen in SOD1-ALS 3/23/2023
Fierce Pharma
MARCH 20, 2023
Eli Lilly CEO racked up $21.4M in 2022 pay as stock price hit all-time high aliu Mon, 03/20/2023 - 10:51
Pharma Times
MARCH 21, 2023
Research data follows phase 3 EMBARK trial and involves men with non-metastatic prostate cancer
Bio Pharma Dive
MARCH 20, 2023
The results add to a growing body of evidence that Karuna’s drug, known as KarXT, could be a valuable new option for patients living with the brain disorder
Pharmaceutical Technology
MARCH 21, 2023
Cannabidiol is the second most prevalent active ingredient in cannabis (marijuana) and for medical purposes it is derived directly from the hemp plant (which is closely related to marijuana) or made in a laboratory.
BioSpace
MARCH 19, 2023
FDA Releases Briefing Docs for Upcoming Biogen/Ionis Tofersen Adcomm 3/20/2023
Fierce Pharma
MARCH 24, 2023
Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst kdunleavy Fri, 03/24/2023 - 07:30
Pharma Times
MARCH 21, 2023
Company raises €12m in financing with a view to entering to the European market
Bio Pharma Dive
MARCH 22, 2023
The Biden administration plans to review federal “march-in” rights and consider whether price could be a reason to take control of patents for drugs developed with government funding
Pharmaceutical Technology
MARCH 23, 2023
Pfizer recently announced an agreement to acquire Seagen, a biotech company based in the US with four marketed oncology therapeutic agents and a rich pipeline.
XTalks
MARCH 24, 2023
It’s without question that webinars have become the go-to marketing tool for organizations looking to grow their global footprint. Take Frost & Sullivan’s data for reference, the market for webinars and virtual events is anticipated to reach $4.44 billion in 2025 — up from $1.57
Fierce Pharma
MARCH 22, 2023
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi fkansteiner Wed, 03/22/2023 - 09:50
Expert insights. Personalized for you.
274 
Let's personalize your content